Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC(1)/VPAC receptors.

Pellesi L, Edvinsson L

Open source

DOI
10.1177/03331024261480167
Published
2026 Aug
Container
Cephalalgia : an international journal of headache
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/03331024261480167,
  title = {Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC(1)/VPAC receptors.},
  author = {Pellesi L and Edvinsson L},
  year = {2026},
  journal = {Cephalalgia : an international journal of headache},
  doi = {10.1177/03331024261480167},
  url = {https://doi.org/10.1177/03331024261480167}
}

RIS

TY  - JOUR
TI  - Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC(1)/VPAC receptors.
AU  - Pellesi L
AU  - Edvinsson L
PY  - 2026
JO  - Cephalalgia : an international journal of headache
DO  - 10.1177/03331024261480167
UR  - https://doi.org/10.1177/03331024261480167
ER  - 

APA

L, P., & L, E. (2026). Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC(1)/VPAC receptors.. Cephalalgia : an international journal of headache. https://doi.org/10.1177/03331024261480167

Source records